BioMarin Pharmaceutical Inc. (BMRN) DCF Valuation

BioMarin Pharmaceutical Inc. (BMRN) DCF Valuation
  • Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • Professional Design: Trusted, Industry-Standard Templates
  • Pre-Built For Quick And Efficient Use
  • No Expertise Is Needed; Easy To Follow

BioMarin Pharmaceutical Inc. (BMRN) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Designed for accuracy, our [BMRN] DCF Calculator enables you to evaluate BioMarin Pharmaceutical Inc. valuation using up-to-date financial data and complete adaptability to modify all essential parameters for improved forecasts.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019
AY2
2020
AY3
2021
AY4
2022
AY5
2023
FY1
2024
FY2
2025
FY3
2026
FY4
2027
FY5
2028
Revenue 1,704.0 1,860.5 1,846.3 2,096.0 2,419.2 2,645.2 2,892.3 3,162.4 3,457.8 3,780.8
Revenue Growth, % 0 9.18 -0.76218 13.53 15.42 9.34 9.34 9.34 9.34 9.34
EBITDA 33.9 -5.9 48.0 267.5 310.3 158.0 172.8 188.9 206.6 225.8
EBITDA, % 1.99 -0.31444 2.6 12.76 12.83 5.97 5.97 5.97 5.97 5.97
Depreciation 105.3 105.9 108.0 102.0 104.4 142.3 155.6 170.2 186.0 203.4
Depreciation, % 6.18 5.69 5.85 4.86 4.31 5.38 5.38 5.38 5.38 5.38
EBIT -71.4 -111.7 -60.0 165.5 205.9 15.7 17.2 18.8 20.5 22.4
EBIT, % -4.19 -6.01 -3.25 7.9 8.51 0.59319 0.59319 0.59319 0.59319 0.59319
Total Cash 753.8 1,065.4 1,013.9 1,291.5 1,073.8 1,388.3 1,518.0 1,659.8 1,814.8 1,984.3
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 377.4 448.4 373.4 461.3 633.7
Account Receivables, % 22.15 24.1 20.22 22.01 26.19
Inventories 680.3 698.5 776.7 894.1 1,107.2 1,100.2 1,202.9 1,315.3 1,438.2 1,572.5
Inventories, % 39.92 37.55 42.07 42.66 45.77 41.59 41.59 41.59 41.59 41.59
Accounts Payable 241.0 191.4 193.0 231.2 315.5 311.9 341.0 372.9 407.7 445.8
Accounts Payable, % 14.14 10.29 10.45 11.03 13.04 11.79 11.79 11.79 11.79 11.79
Capital Expenditure -163.4 -137.5 -119.2 -131.5 -107.6 -180.7 -197.6 -216.1 -236.3 -258.3
Capital Expenditure, % -9.59 -7.39 -6.46 -6.28 -4.45 -6.83 -6.83 -6.83 -6.83 -6.83
Tax Rate, % 11.09 11.09 11.09 11.09 11.09 11.09 11.09 11.09 11.09 11.09
EBITAT -17.9 2,254.6 -51.0 156.7 183.1 9.2 10.1 11.0 12.1 13.2
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -892.8 2,084.2 -63.8 -40.0 -121.4 1.2 -162.2 -177.4 -193.9 -212.1
WACC, % 5.54 5.45 5.75 5.78 5.76 5.65 5.65 5.65 5.65 5.65
PV UFCF
SUM PV UFCF -611.3
Long Term Growth Rate, % 4.00
Free cash flow (T + 1) -221
Terminal Value -13,339
Present Terminal Value -10,132
Enterprise Value -10,743
Net Debt 341
Equity Value -11,084
Diluted Shares Outstanding, MM 192
Equity Value Per Share -57.85

What You Will Get

  • Real BMRN Financial Data: Pre-filled with BioMarin's historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See BioMarin’s intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Real-Life BMRN Data: Pre-filled with BioMarin's historical financials and future growth estimates.
  • Fully Customizable Inputs: Modify revenue growth rates, profit margins, discount rates, tax assumptions, and capital investments.
  • Dynamic Valuation Model: Automatic recalculations of Net Present Value (NPV) and intrinsic value based on user-defined inputs.
  • Scenario Testing: Develop various forecast scenarios to evaluate different valuation results.
  • User-Friendly Design: Intuitive layout, crafted for both industry professionals and newcomers.

How It Works

  • Download: Obtain the pre-built Excel file containing BioMarin Pharmaceutical Inc. (BMRN) financial data.
  • Customize: Modify projections, such as revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Generate various forecasts and instantly compare results.
  • Make Decisions: Utilize the valuation findings to inform your investment strategy.

Why Choose This Calculator for BioMarin Pharmaceutical Inc. (BMRN)?

  • Accurate Data: Real BioMarin financials guarantee trustworthy valuation outcomes.
  • Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
  • Time-Saving: Pre-built calculations save you the hassle of starting from the ground up.
  • Professional-Grade Tool: Tailored for investors, analysts, and consultants in the pharmaceutical sector.
  • User-Friendly: Easy-to-navigate design and comprehensive instructions ensure accessibility for all users.

Who Should Use This Product?

  • Pharmaceutical Students: Explore drug development processes and apply them using real-world case studies.
  • Researchers: Integrate advanced biopharmaceutical models into academic projects or publications.
  • Investors: Evaluate your investment strategies and analyze valuation metrics for BioMarin Pharmaceutical Inc. (BMRN).
  • Market Analysts: Enhance your analysis with a ready-to-use, customizable financial model tailored for the biotech sector.
  • Healthcare Entrepreneurs: Understand the valuation methods applied to leading biotech firms like BioMarin Pharmaceutical Inc. (BMRN).

What the Template Contains

  • Pre-Filled DCF Model: BioMarin Pharmaceutical Inc.’s (BMRN) financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate BioMarin’s profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.